We synthesized new [Cu(NN)(2)](+)-type complexes where NN = 2-5 and denotes a 2,9-disubstituted-1,10-phenanthroline ligand (related complexes of 1 and 6 ligands are used for reference purposes). For 2, 3, and 4 the ligand substituents are long alkyl-type fragments, whereas in 5 a phenyl ring is directly attached to the chelating unit. At 298 K the four complexes display relatively intense metal-to-ligand-charge-transfer (MLCT) emission bands with maxima around 720 nm, Phi(em) approximately 1 x 10(-)(3) and tau > 100 ns in deaerated CH(2)Cl(2). The emission behavior at 77 K in a CH(2)Cl(2)/MeOH matrix is quite different for complexes of alkyl- (2-4) versus phenyl-substituted (5) ligands. The former exhibit very intense emission bands centered around 642 nm and hypsochromically shifted with respect to 298 K, whereas the luminescence band of [Cu(5)(2)](+) is faint and shifted toward the infrared side. These results prompted us to study in detail the temperature dependence of luminescence properties of [Cu(2)(2)](+) and [Cu(5)(2)](+) in the 300-96 K range. For both complexes the excited state lifetimes increase monotonically by decreasing temperatures, and the trend is well described by an Arrhenius-type treatment involving two equilibrated MLCT excited levels. The emission bands show a similar behavior for the two compounds (intensity decrease and red-shift) only in the 300-120 K range, when the solvent is fluid. In the frozen regime (T </= 120 K), the emission intensity of [Cu(5)(2)](+) continues to drop, whereas that of [Cu(2)(2)](+) exhibits a dramatic intensity increase. We interpret this different behavior in terms of structural factors, suggesting that long alkyl-chains in the 2,9-phenanthroline positions are optimal to prevent significant ground- and excited-state distortions in rigid matrix. We show that our results do not contradict current models describing the photophysics of [Cu(NN)(2)](+) but, instead, bring further evidence to support their validity. They also suggest guidelines for the design of Cu(I)-phenanthroline complexes showing optimized luminescence performances both in fluid and in rigid matrix, an elusive goal for over two decades.
No takes yet. Share an insight, caveat, or question.
Felder et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: